Waterloo Quantum Breakthrough Neurodegenerative Treatment | AcademicJobs.ca
University of Waterloo researchers harness quantum effects to alter tubulin proteins, offering hope for non-invasive treatments for Alzheimer's and Parkinson's in Canada.
No reviews yet. Be the first to rate Travis!
Dr. Travis Craddock is an Associate Professor in the Department of Biology at the University of Waterloo and the Tier 1 Canada Research Chair in Quantum Neurobiology. He earned a B.Sc. in Physics (Co-op) from the University of Guelph in 2002, followed by an M.Sc. in Physics in 2008 and a Ph.D. in Physics in 2012, both from the University of Alberta. Prior to joining the University of Waterloo in May 2024, he served as an Associate Professor of Neuroscience at Nova Southeastern University and as Director of Clinical Systems Biology at the Institute for Neuro-Immune Medicine. His research examines quantum neurobiological mechanisms of neuroinflammation, cellular information processes, molecular neuroscience, and the biophysics of neurological and neurodegenerative diseases, with a focus on developing novel diagnostics and therapeutics for conditions such as Alzheimer’s disease and Parkinson’s disease. Craddock investigates whether biological systems utilize quantum-level processes and applies computational biophysics, systems biology, and quantum biology approaches to study neuroinflammation and related disorders.
Craddock holds the Tier 1 Canada Research Chair in Quantum Neurobiology, awarded in 2024. Additional honors include funding from the Canadian Foundation for Innovation John R. Evans Leaders Fund in 2025 for research on biophysical mechanisms of neuroinflammation leading to neurodegeneration and support from the Gateway Institute for Brain Research in 2025 for accelerating quantum biology research in Parkinson’s disease. He serves as Associate Editor for Computational and Structural Biotechnology Journal in the area of Quantum Biology & Biophotonics and as Associate Editor for Frontiers in Systems Neuroscience. He is a member of the University of Waterloo Indigenous Faculty Council and has contributed to editorial roles and peer review for the Department of Defense Peer Reviewed Medical Research Program. Recent publications include work on tubulin polymerization dynamics influenced by magnetic isotope effects in Science Advances (2026), optical properties of the cytoskeleton in Journal of Physics: Photonics (2026), and quantum information flow in microtubule tryptophan networks in Entropy (2026). His scholarship bridges physics and biology to advance understanding of fundamental processes in the brain and their implications for health.
University of Waterloo researchers harness quantum effects to alter tubulin proteins, offering hope for non-invasive treatments for Alzheimer's and Parkinson's in Canada.
Discover how University of Waterloo scientists used weak magnetic fields and isotopes to manipulate tubulin proteins, offering new hope for Alzheimer's and Parkinson's via quantum biology principles.